{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:20:50Z","timestamp":1755224450675,"version":"3.43.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study aimed to clarify the correlation of hepatitis C genotype with hepatitis C virus (HCV)-RNA, red blood cell (RBC)-related parameters (i.e., RBC count, hemoglobin concentration [HGB], mean corpuscular volume, RBC distribution width-standard deviation, RBC distribution width-coefficient of variability) and blood platelet (PLT) count, providing a reference basis to clinicians for diagnosing and treating hepatitis C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Hepatitis C genotyping, RBC-related parameters, PLT count, hepatitis C virus ribonucleic acid (HCV-RNA) logarithmic values (lg) and HCV antibodies (anti-HCV; ratio of the measured value to the critical value [S\/CO]) were detected in 168 patients with chronic hepatitis C.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Compared with the non-type I group, differences were found in HCV-RNA (lg) and anti-HCV in the type I group (<jats:italic toggle=\"yes\">P\u2005&lt;\u2005<\/jats:italic>.05). Compared with the negative group, significant differences were noted in anti-HCV (S\/CO) in the type I and non-type I groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01). The RBC count and HGB of the type I group were significantly lower than those of the non-type I and negative groups. The PLT count of the 3 groups increased sequentially, with all groups exhibiting significant differences (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). HCV-RNA (lg) was significantly negatively correlated with RBC count, HGB and PLT count (<jats:italic toggle=\"yes\">P\u2005&lt;\u2005<\/jats:italic>.05). The analysis of the receiver operating characteristic curve and its area under the curve indicates that RBC count, HGB, mean corpuscular volume reciprocal and PLT count exhibit certain clinical reference value for determining whether HCVs are replicating.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Clinicians should closely monitor changes in blood cell-related indicators before and after antiviral treatment and then develop personalized treatment plans for patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043237","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:00:09Z","timestamp":1752516009000},"page":"e43237","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of hepatitis C genotype with HCV-RNA, RBC-related parameters, and blood platelet count"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7416-094X","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"first","affiliation":[{"name":"Dingxi People\u2019s Hospital, Dingxi, Gansu Province, China"},{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Xi\u2019an Jiao tong University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Li","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Liang","sequence":"additional","affiliation":[{"name":"Dingxi People\u2019s Hospital, Dingxi, Gansu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Xi\u2019an Jiao tong University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Xi\u2019an Jiao tong University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250812","article-title":"Hepatitis C."},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1002\/jmv.27877","article-title":"Sofosbuvir-based therapy for late pregnant women and infant with severe chronic hepatitis C: a case series study.","volume":"94","author":"Zeng","year":"2022","journal-title":"J Med Virol"},{"key":"R3-20250812","first-page":"3109","article-title":"Prevalence of hepatitis C virus infection among healthy population undergoing physical examination in a hospital of Tianjin and immunological type.","volume":"32","author":"Feng","year":"2022","journal-title":"Chin J Nosocomiol"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CM9.0000000000000629","article-title":"Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort.","volume":"133","author":"Nan","year":"2020","journal-title":"Chin Med J"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"e25127","DOI":"10.1002\/jcla.25127","article-title":"Laboratory biochemical and hematological parameters: early predictive biomarkers for diagnosing hepatitis C virus infection.","volume":"38","author":"Bagheri","year":"2024","journal-title":"J Clin Lab Anal"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"177","DOI":"10.12775\/JEHS.2020.10.02.023","article-title":"Dependence of changes in hematological and integrative parameters in patients with chronic viral hepatitis C on the received antiviral therapy.","volume":"10","author":"Lishnevska","year":"2020","journal-title":"J Educ Health Sport"},{"key":"R7-20250812","first-page":"281","article-title":"Coexistence of HBsAg\/Anti-HBs and HBeAg\/Anti-HBe in sudanese patients with chronic hepatitis B virus infection: a cross-sectional study.","volume":"13","author":"Hashim","year":"2023","journal-title":"Int J Biomed"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"199567","DOI":"10.1016\/j.virusres.2025.199567","article-title":"HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases.","volume":"355","author":"Pu","year":"2025","journal-title":"Virus Res"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.7150\/ijbs.55724","article-title":"Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: causes and consequences.","volume":"17","author":"Jiang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12985-020-01316-y","article-title":"Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China,and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data.","volume":"17","author":"Li","year":"2020","journal-title":"Virol J"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15419\/ajhs.v8i2.516","article-title":"Altered hematological parameters in HCV infection: a diagnostic approach.","volume":"8","author":"Rasheed","year":"2022","journal-title":"Asian J Health Sci"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12879-017-2775-0","article-title":"The future of viral hepatitis testing: innovations in testing technologies and approaches.","volume":"17","author":"Peeling","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"101626","DOI":"10.1016\/j.clinre.2021.101626","article-title":"HCV virology and diagnosis.","volume":"45","author":"Roger","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.kint.2018.11.038","article-title":"Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.","volume":"95","author":"Jadoul","year":"2019","journal-title":"Kidney Int"},{"key":"R15-20250812","first-page":"41","article-title":"Effect of hepatitis C virus (HCV) on hemoglobin, blood cells and random blood glucose levels among serologically positive HCV patients.","volume":"6","author":"Asaduzzaman","year":"2017","journal-title":"IOSR J Nurs Health Sci"},{"key":"R16-20250812","first-page":"29","article-title":"Guidelines for the prevention and treatment of hepatitis C (2022 Edition).","volume":"41","year":"2023","journal-title":"Chin J Infect Dis"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"e0234577","DOI":"10.1371\/journal.pone.0234577","article-title":"Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care.","volume":"15","author":"David","year":"2020","journal-title":"PLoS One"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cells8101249","article-title":"Mechanisms underlying hepatitis C virusassociated hepatic fibrosis.","volume":"8","author":"Khatun","year":"2019","journal-title":"Cells"},{"key":"R20-20250812","first-page":"414","article-title":"Analysis of hepatitis C virus 5\u2019non-coding region for viral genotyping and the level of viral replication.","volume":"31","author":"Wang","year":"2017","journal-title":"Chin J Exp Clin Virol"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1111\/liv.14628","article-title":"Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in England.","volume":"40","author":"Mohamed","year":"2020","journal-title":"Liver Int"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jmv.25083","article-title":"The role of IDO, IL-10, and TGF-\u03b2 in the HCV-associated chronic hepatitis,liver cirrhosis, and hepatocellular carcinoma.","volume":"91","author":"Yang","year":"2019","journal-title":"J Med Virol"},{"key":"R23-20250812","first-page":"1397","article-title":"Analysis of HCV-RNA levels and genotyping results in patients with hepatitis C in Xinjiang.","volume":"13","author":"Zhou","year":"2018","journal-title":"J Path Biol"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12664-017-0745-5","article-title":"Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients.","volume":"36","author":"Goel","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection.","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.healun.2020.06.022","article-title":"Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.","volume":"39","author":"Gidea","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.healun.2021.05.018","article-title":"Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.","volume":"40","author":"Madan","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2009.11.017","article-title":"Hepatitis C virus viremia and low platelet count: a study in a hepatitis B&C end emic area in Taiwan.","volume":"52","author":"Dai","year":"2010","journal-title":"J Hepatol"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"e0238035","DOI":"10.1371\/journal.pone.0238035","article-title":"Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa.","volume":"15","author":"Duchesne","year":"2020","journal-title":"PLoS One"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41598-020-58786-x","article-title":"Hepatitis C virus clearance with glucose improvement and factors afecting the glucose control in chronic hepatitis C patients.","volume":"10","author":"Yuan","year":"2020","journal-title":"Sci Rep"},{"key":"R32-20250812","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12664-020-01038-7","article-title":"Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver disease.","volume":"39","author":"Catanzaro","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"R33-20250812","doi-asserted-by":"crossref","first-page":"19744","DOI":"10.1038\/s41598-020-76871-z","article-title":"Evolution of ferritin levels in hepatitis C patients treated with antivirals.","volume":"10","author":"Chang","year":"2020","journal-title":"Sci Rep"},{"key":"R34-20250812","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","article-title":"A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.","volume":"37","author":"Kajihara","year":"2003","journal-title":"Hepatology"},{"key":"R35-20250812","doi-asserted-by":"crossref","first-page":"e20156","DOI":"10.1097\/MD.0000000000020156","article-title":"Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R36-20250812","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12876-021-01606-x","article-title":"Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy.","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"R37-20250812","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/tropicalmed8110502","article-title":"Hepatitis C virus infection in the elderly in the era of direct-acting antivirals: evidence from clinical trials and real life.","volume":"8","author":"Pugliese","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"R38-20250812","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.31003","article-title":"Short-duration pan-genotypic therapy with glecaprevir\/pibrentasvir for 6 weeks among people with recent hepatitis C viral infection.","volume":"72","author":"Martinello","year":"2020","journal-title":"Hepatology"},{"key":"R39-20250812","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199809103391107","article-title":"Thrombopoietin.","volume":"339","author":"Kaushansky","year":"1998","journal-title":"N Engl J Med"},{"key":"R40-20250812","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/09537104.2018.1542125","article-title":"Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?","volume":"30","author":"Olson","year":"2019","journal-title":"Platelets"},{"key":"R41-20250812","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MEG.0000000000001786","article-title":"Efficacy of sofosbuvir\/velpatasvir\/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus.","volume":"33","author":"Da","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R42-20250812","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/jcm10040877","article-title":"Thrombocytopenia in virus infections.","volume":"10","author":"Raadsen","year":"2021","journal-title":"J Clin Med"},{"key":"R43-20250812","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5144\/0256-4947.2022.89","article-title":"Follow-up post-HCV virological response to DAA in advanced chronic liver disease.","volume":"42","author":"Alswat","year":"2022","journal-title":"Ann Saudi Med"},{"key":"R44-20250812","doi-asserted-by":"crossref","first-page":"e2412378","DOI":"10.1002\/advs.202412378","article-title":"Exosome-mediated lectin pathway and resistin-MIF-AA metabolism axis drive immune dysfunction in immune thrombocytopenia.","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci"},{"key":"R45-20250812","doi-asserted-by":"crossref","first-page":"1103737","DOI":"10.3389\/fviro.2023.1103737","article-title":"Malignancy and viral infections in Sub-Saharan Africa: a review.","volume":"3","author":"Diakite","year":"2023","journal-title":"Front Virol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:00:50Z","timestamp":1755018050000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":45,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043237","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}